Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc.verified

VTYX

Price:

$4.73

Market Cap:

$333.46M

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of syst...[Read more]

Industry

Biotechnology

IPO Date

2021-10-21

Stock Exchange

NASDAQ

Ticker

VTYX

The Enterprise Value as of May 2024 (TTM) for Ventyx Biosciences, Inc. (VTYX) is 203.06M

According to Ventyx Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 203.06M. This represents a change of -80.63% compared to the average of 1.05B of the last 4 quarters.

Ventyx Biosciences, Inc. (VTYX) Historical Enterprise Value (quarterly & annually)

How has VTYX Enterprise Value performed in the past?

The mean historical Enterprise Value of Ventyx Biosciences, Inc. over the last ten years is 964.70M. The current 203.06M Enterprise Value has changed 2.00% with respect to the historical average. Over the past ten years (40 quarters), VTYX's Enterprise Value was at its highest in in the September 2023 quarter at 2.00B. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

964.70M

Median

1.06B

Minimum

105.53M

Maximum

1.66B

Ventyx Biosciences, Inc. (VTYX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ventyx Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 78.14%

Maximum Annual Enterprise Value = 1.66B

Minimum Annual Increase = -93.63%

Minimum Annual Enterprise Value = 105.53M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023105.53M-93.63%
20221.66B78.14%
2021930.33M-13.02%
20201.07B0.84%

Ventyx Biosciences, Inc. (VTYX) Average Enterprise Value

How has VTYX Enterprise Value performed in the past?

The current Enterprise Value of Ventyx Biosciences, Inc. (VTYX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

897.71M

5-year avg

964.70M

10-year avg

964.70M

Ventyx Biosciences, Inc. (VTYX) Enterprise Value vs. Peers

How is VTYX’s Enterprise Value compared to its peers?

Ventyx Biosciences, Inc.’s Enterprise Value is less than Arcellx, Inc. (2.80B), less than Immunocore Holdings plc (1.74B), less than Vaxcyte, Inc. (7.53B), less than DICE Therapeutics, Inc. (2.21B), less than Nuvalent, Inc. (4.48B), less than Cerevel Therapeutics Holdings, Inc. (7.72B), less than Travere Therapeutics, Inc. (822.11M), less than Structure Therapeutics Inc. (1.59B), less than Replimune Group, Inc. (0), less than Ascendis Pharma A/S (396.75M), less than United Therapeutics Corporation (6.66B), less than IDEAYA Biosciences, Inc. (11.52B), less than Protagonist Therapeutics, Inc. (2.96B), less than Verona Pharma plc (1.63B), less than Syndax Pharmaceuticals, Inc. (848.37M), less than null (1.61B),

Build a custom stock screener for Ventyx Biosciences, Inc. (VTYX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ventyx Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ventyx Biosciences, Inc. (VTYX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ventyx Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Ventyx Biosciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Ventyx Biosciences, Inc. (VTYX)?

What is the 3-year average Enterprise Value for Ventyx Biosciences, Inc. (VTYX)?

What is the 5-year average Enterprise Value for Ventyx Biosciences, Inc. (VTYX)?

How does the current Enterprise Value for Ventyx Biosciences, Inc. (VTYX) compare to its historical average?